Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Tumor-Agnostic 1Lymphoid 1Breast 1

Conditions

Prostatic Neoplasms 14Neoplasms 3Testicular Neoplasms 2Metabolic Syndrome 2Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Metabolic Diseases 1Hypogonadism 1Eunuchism 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

pembrolizumab 28Docetaxel 21Gemcitabine 19Nivolumab 15Paclitaxel 13Prednisone 12Leuprolide 11pazopanib 10Radiotherapy 10Cisplatin 10Sunitinib 9Sorafenib 9Ipilimumab 8Blood Specimen Collection 8Bevacizumab 8avelumab 7atezolizumab 7Therapeutics 7Thalidomide 7Cyclophosphamide 7Carboplatin 7Standard of Care 6Radiation 6Mitomycin 6Interleukin-2 6Cetuximab 6Axitinib 6padeliporfin 5enzalutamide 5cemiplimab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Testosterone × Genitourinary × Clear all
NCT01187485 2023-11-29

A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

University of Chicago

Phase 1 Completed
15 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00587431 2023-11-07

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
102 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00515112 2014-06-11

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

University of Chicago

Phase 2 Terminated
6 enrolled 4 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡